-
E3N is a French prospective study of cancer risk factorsEtude Epidémiologique de femmes de la Mutuelle Générale de lEduction National. The study population, after exclusions, consists of 54,548 women born between 1925 and 1950, and all belong to a health insurance program that primarily covers teachers.
-
A surprising study recently surfaced in the British Medical Journal. A randomized trial was designed to determine if giving a standard maternal dose of steroids (two injections of 12 mg of betamethasone separated by 24 hours) would decrease the incidence of respiratory distress syndrome (RDS) in infants whose mothers were to have elective Cesarean sections.
-
I missed this article when it first emerged. however, during a recent perinatal conference in California, Dr. Michael Nageotte cited it in an excellent lecture on breeches. Since the report could have an impact in current practice, I am reviewing it in this issue.
-
Beta-Blockers Therapy for the Treatment of Hypertension; Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions
-
Tipranavir is a recently approved protease inhibitor for the treatment of HIV-1 infections. It is a selective non-peptide HIV-1 protease inhibitor for treatment-experienced adults with resistance to multiple protease inhibitors. Tipranavir is marketed by Boehringer Ingelheim as Aptivus®.
-
Cola consumption, but not caffeine per se, was associated with increased risk of developing hypertension over a 12-year period.
-
-
Doxycycline Hyclate 20 mg Tablets and Metronidazole 0.75% Topical Lotion in the Treatment of Rosacea; Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation; Comorbid Depression with Mortality in Patients with DM
-
A new injectable diabetes medication in the family of incretin mimetic drugs has been shown to be as effective as insulin in controlling average blood sugars in Type 2 diabetics who are difficult to control on oral medications, without as much associated weight gain.
-
A meta-analysis comparing percutaneous balloon angioplasty alone vs coronary artery bypass grafting (CABG) demonstrated no significant differences in mortality and nonfatal myocardial infarction (MI) however, a statistically significant benefit in terms of survival in favor of surgery1 was noted.